Send mail to Author

Correction : phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas (Article)

Please indicate your contact information and select, which author you want to contact.



 
 __   __     ___      ______    ______    _  __   _    _   
 \ \\/ //   / _ \\   /_____//  /_   _//  | |/ // | || | || 
  \   //   | / \ ||  `____ `    -| ||-   | ' //  | || | || 
  / . \\   | \_/ ||  /___//     _| ||_   | . \\  | \\_/ || 
 /_//\_\\   \___//   `__ `     /_____//  |_|\_\\  \____//  
 `-`  --`   `---`    /_//      `-----`   `-` --`   `---`   
                     `-`
 


Back to frontdoor view

OPUS4 Logo